File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0021885370
- PMID: 2858744
- WOS: WOS:A1985AFM9000002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Evidence that respiratory tract is major reservoir for Epstein-Barr virus
Title | Evidence that respiratory tract is major reservoir for Epstein-Barr virus |
---|---|
Authors | |
Issue Date | 1985 |
Publisher | The Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lancet |
Citation | Lancet, 1985, v. 1 n. 8434, p. 889-892 How to Cite? |
Abstract | Exfoliated cells harvested from bronchial washings of 53 patients with suspected bronchogenic carcinoma were tested by means of DNA dot hybridisation using the cloned large internal repeat (IR) sequence of Epstein-Barr virus (EBV) genome as a probe. 25 of these patients gave positive results. Since the patients had diseases that were not related to the virus, this finding suggests that the lower respiratory tract is a major reservoir for EBV. Attempts at cellular localisation of the virus revealed only an occasional cell which harboured the viral genome or expressed viral capsid antigens. These cells could not account for the quantity of the viral DNA detected in bronchial washings. Moreover, patients had similar profiles of serum EBV antibodies whether they were positive or negative for EBV DNA by dot hybridisation. These findings are compatible with a state of viral latency in which cells harbour a low copy number of the viral genome. Viral expression rarely occurs in these cells, which seem to elicit a minimum host immune response. If it is assumed that each latency infected cell harbours a maximum of approximately 30 EBV genomes (which is the lower limit of detection by the in-situ hybridisation method used in this study), the findings suggest that a considerable proportion of the exfoliative cells from the lower respiratory tract, of the order of 0.1-16% harbour latent EBV. |
Persistent Identifier | http://hdl.handle.net/10722/150682 |
ISSN | 2023 Impact Factor: 98.4 2023 SCImago Journal Rankings: 12.113 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lung, ML | en_US |
dc.contributor.author | Lam, WK | en_US |
dc.contributor.author | So, SY | en_US |
dc.date.accessioned | 2012-06-26T06:08:39Z | - |
dc.date.available | 2012-06-26T06:08:39Z | - |
dc.date.issued | 1985 | en_US |
dc.identifier.citation | Lancet, 1985, v. 1 n. 8434, p. 889-892 | en_US |
dc.identifier.issn | 0140-6736 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/150682 | - |
dc.description.abstract | Exfoliated cells harvested from bronchial washings of 53 patients with suspected bronchogenic carcinoma were tested by means of DNA dot hybridisation using the cloned large internal repeat (IR) sequence of Epstein-Barr virus (EBV) genome as a probe. 25 of these patients gave positive results. Since the patients had diseases that were not related to the virus, this finding suggests that the lower respiratory tract is a major reservoir for EBV. Attempts at cellular localisation of the virus revealed only an occasional cell which harboured the viral genome or expressed viral capsid antigens. These cells could not account for the quantity of the viral DNA detected in bronchial washings. Moreover, patients had similar profiles of serum EBV antibodies whether they were positive or negative for EBV DNA by dot hybridisation. These findings are compatible with a state of viral latency in which cells harbour a low copy number of the viral genome. Viral expression rarely occurs in these cells, which seem to elicit a minimum host immune response. If it is assumed that each latency infected cell harbours a maximum of approximately 30 EBV genomes (which is the lower limit of detection by the in-situ hybridisation method used in this study), the findings suggest that a considerable proportion of the exfoliative cells from the lower respiratory tract, of the order of 0.1-16% harbour latent EBV. | en_US |
dc.language | eng | en_US |
dc.publisher | The Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lancet | en_US |
dc.relation.ispartof | Lancet | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Antigens, Viral - Analysis | en_US |
dc.subject.mesh | Bronchi - Microbiology | en_US |
dc.subject.mesh | Carcinoma, Bronchogenic - Microbiology | en_US |
dc.subject.mesh | Dna, Viral - Analysis | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Herpesvirus 4, Human - Genetics - Immunology - Isolation & Purification | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Lung Neoplasms - Microbiology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Nucleic Acid Hybridization | en_US |
dc.subject.mesh | Retroviridae Infections - Microbiology | en_US |
dc.title | Evidence that respiratory tract is major reservoir for Epstein-Barr virus | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lung, ML:mlilung@hku.hk | en_US |
dc.identifier.authority | Lung, ML=rp00300 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 2858744 | - |
dc.identifier.scopus | eid_2-s2.0-0021885370 | en_US |
dc.identifier.volume | 1 | en_US |
dc.identifier.issue | 8434 | en_US |
dc.identifier.spage | 889 | en_US |
dc.identifier.epage | 892 | en_US |
dc.identifier.isi | WOS:A1985AFM9000002 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Lung, ML=7006411788 | en_US |
dc.identifier.scopusauthorid | Lam, WK=7203021937 | en_US |
dc.identifier.scopusauthorid | So, SY=7102397816 | en_US |
dc.identifier.issnl | 0140-6736 | - |